Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study

References

Page 1

	Year	Citations
Epidemiology in Medicine. Annals of Internal Medicine Infectious Disease EpidemiologyPreventive MedicineEpidemiological OutcomeClinical EpidemiologyEpidemiologic Research	1988	1.9K
Multiple Risk Factor Intervention Trial Deborah M. Michel JAMA	1982	1.7K
Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls Salvador Moncada, John R. Vane New England Journal of Medicine Lipid AnalysisDouble BondsArachidonic Acid MetabolitesBlood-vessel WallsThrombosis	1979	1.2K
Secondary prevention of vascular disease by prolonged antiplatelet treatment BMJ Prolonged Antiplatelet TreatmentPharmacotherapyAcute Myocardial InfarctionThrombosisStroke	1988	1K
Influence of Adherence to Treatment and Response of Cholesterol on Mortality in the Coronary Drug Project New England Journal of Medicine Heart FailureCoronary Drug ProjectCardiovascular PharmacologyPharmacotherapyPreventive Cardiology	1980	656
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study New England Journal of Medicine Evidence-based MedicinePharmacotherapyPreventive CardiologyAspirin ComponentAdverse Drug Reaction	1988	520
Cancer Statistics, 1988 E Silverberg, J. A. Lubera CA A Cancer Journal for Clinicians	1988	282
The 2 × 2 factorial design: Its application to a randomized trial of aspirin and U.S. physicians Meir J. Stampfer, Julie E. Buring, Walter C. Willett, Statistics in Medicine	1985	121
Aspirin and coronary heart disease: findings of a prospective study. Edward Hammond, Lawrence Garfinkel BMJ	1975	83
A case-control study of regular aspirin use and coronary deaths. Charles H. Hennekens, Lynne K. Karlson, Bernard Rosner Circulation PharmacotherapyPreventive CardiologyLogistic AnalysisCoronary Artery DiseaseProspective Cohort Study	1978	57

Page 1